VTAK — Catheter Precision Income Statement
0.000.00%
- $2.98m
- $1.78m
- $0.42m
- 18
- 39
- 16
- 13
Annual income statement for Catheter Precision, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.259 | 0.022 | 0.014 | 0.442 | 0.42 |
Cost of Revenue | |||||
Gross Profit | -1.91 | -1.54 | -0.147 | 0.412 | 0.378 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 35.7 | 27.3 | 27 | 78.6 | 11.7 |
Operating Profit | -35.4 | -27.2 | -27 | -78.1 | -11.2 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -35.3 | -27.3 | -26.9 | -70.6 | -13.5 |
Provision for Income Taxes | |||||
Net Income After Taxes | -35.3 | -27.3 | -26.9 | -70.6 | -16.6 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -36 | -25.1 | -26.9 | -70.6 | -16.6 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -36 | -25.1 | -26.9 | -71.4 | -21.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -10,394 | -2,827 | -234 | -19 | -6.68 |